Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion
about
Tumor and stromal-based contributions to head and neck squamous cell carcinoma invasionMetastatic mechanisms in follicular cell-derived thyroid cancerBRAF activates and physically interacts with PAK to regulate cell motilityGroup I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cellsFollicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice.P21-activated kinase 4 involves TSH induced papillary thyroid cancer cell proliferation.Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration.Republished: tracing PAKs from GI inflammation to cancerMetastatic dormancy and progression in thyroid cancer: targeting cells in the metastatic frontier.Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.Potent inhibition of angiogenesis by the IGF-1 receptor-targeting antibody SCH717454 is reversed by IGF-2.Overexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinomaRCAN1-4 is a thyroid cancer growth and metastasis suppressor.Tracing PAKs from GI inflammation to cancer.Clinicopathological and cellular signature of PAK1 in human bladder cancer.Association of p21-activated kinase-1 activity with aggressive tumor behavior and poor prognosis of head and neck cancer.Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.Analysis of exosome release as a cellular response to MAPK pathway inhibition.Personalizing risk stratification by addition of PAK1 expression to TNM staging: improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma.
P2860
Q26825164-DD8486AC-EB55-4092-B6BF-D029BC5975C1Q27005646-B454E2A2-1964-4C0C-9618-4128D9987056Q28248127-7E148276-EE97-4DB7-A8D6-44325C9458A1Q28541395-4279104D-12CF-48BF-B0FE-C0EC8F7F4A88Q33569087-100B3338-8498-4447-9DA4-F6984949710AQ33648683-C1A412F5-C9E5-4B08-A3ED-EB0DDB436F9DQ34346905-27B084EB-D7C3-4CCC-B88C-E9071BE9D0ECQ34463139-081E191B-0079-4FC4-BB2D-3BF43BADE436Q34975148-BE1E000B-1BB5-4F34-B78E-B18AC885DE9EQ36078608-2E0138D5-4DDC-41C3-8C06-A2A4F3699A3AQ36170917-5093CB70-9A4E-4F19-8F03-BA6E12CEB678Q36511751-F6DDD719-B729-4FD6-9B88-0FD31FFAC705Q37677411-6146F102-BB95-44D6-A4F9-B2540AA8CB42Q38210506-173E59B7-4BF4-4B4E-80A2-64CC854B6644Q38938813-ED726474-54E1-4382-9158-CDE517ED51FAQ39014879-E3ADF2EF-CF39-4659-8016-9B881959A6DAQ40534803-3DCD05EF-3205-4D75-994F-722D4C2B5F48Q41572429-D1EC3568-D071-4834-A527-BBFC9BDED35AQ54326940-06A085E9-320D-4A77-8B00-FC21A21373DE
P2860
Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Group I p21-activated kinases ...... ted in thyroid cancer invasion
@en
Group I p21-activated kinases ...... ed in thyroid cancer invasion.
@nl
type
label
Group I p21-activated kinases ...... ted in thyroid cancer invasion
@en
Group I p21-activated kinases ...... ed in thyroid cancer invasion.
@nl
prefLabel
Group I p21-activated kinases ...... ted in thyroid cancer invasion
@en
Group I p21-activated kinases ...... ed in thyroid cancer invasion.
@nl
P2093
P2860
P356
P1476
Group I p21-activated kinases ...... ted in thyroid cancer invasion
@en
P2093
Alfredo Fusco
David Jarjoura
Matthew D Ringel
Motoyasu Saji
Samantha K McCarty
Vasyl V Vasko
Xiaoli Zhang
P2860
P304
P356
10.1677/ERC-10-0168
P577
2010-10-29T00:00:00Z